Brief: Enorama Pharma Q3 EBIT Loss Narrows To SEK 7.1 Mln

Enorama Pharma AB

17/11/2022 06:23

Nov 17 (Reuters) - Enorama Pharma AB  ERMA.ST :
    * SAID ON WEDNESDAY Q3 NET SALES SEK 3.9 MLN VS SEK 1.4 MLN
YR AGO
    * Q3 EBIT LOSS SEK 7.1 MLN VS LOSS SEK 8.2 MLN YR AGO
    * PLANS EQUITY ISSUANCE IN NEAR FUTURE AS COMPANY HAS
IMMEDIATE
NEED FOR STRENGTHENED BALANCED SHEET, INCREASED LIQUIDITY 

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr9l7sDS
 Further company coverage:  ERMA.ST  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))